Cargando…
Immunohistochemical overexpression of BCL-2 protein predicts an inferior survival in patients with primary central nervous system diffuse large B-cell lymphoma
This study was designed to analyze the clinical characteristics and prognostic value of c-MYC and BCL-2 proteins expression in patients with primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL). 82 patients newly diagnosed with PCNS-DLBCL, from January 2008 to November 2018, wer...
Autores principales: | Chen, Yi, Chen, Hong, Chen, Lushan, Zheng, Xiaoyun, Yang, Xiaozhu, Zheng, Zhihong, Zheng, Jing, Yang, Ting, Liu, Tingbo, Yang, Yinghong, Hu, Jianda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855480/ https://www.ncbi.nlm.nih.gov/pubmed/31702637 http://dx.doi.org/10.1097/MD.0000000000017827 |
Ejemplares similares
-
The outcome and prognostic factors of 248 elderly patients with acute myeloid leukemia treated with standard-dose or low-intensity induction therapy
por: Chen, Yi, et al.
Publicado: (2016) -
IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era
por: Chen, Xiangli, et al.
Publicado: (2020) -
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study
por: Schiefer, Ana-Iris, et al.
Publicado: (2015) -
A long-term retrospective study on sporadic Burkitt lymphoma in chinese population
por: Yang, Xiaoyun, et al.
Publicado: (2020) -
Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP
por: Wang, Jing, et al.
Publicado: (2016)